Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for:...
FDA Recall #D-0241-2026 — Class II — December 12, 2025
Product Description
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Reason for Recall
Presence of particulate matter: potential presence of metal particulates in the product.
Recalling Firm
Merck Sharp & Dohme LLC — Wilson, NC
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
3 - single dose kits
Distribution
Nationwide in the USA
Code Information
Lot #: Z014503, Exp 11/15/2027
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated